AROSIO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 4.839
AS - Asia 2.685
EU - Europa 2.398
SA - Sud America 364
AF - Africa 64
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.362
Nazione #
US - Stati Uniti d'America 4.537
SG - Singapore 980
CN - Cina 627
IT - Italia 468
VN - Vietnam 342
DE - Germania 325
RU - Federazione Russa 310
BR - Brasile 291
HK - Hong Kong 269
CA - Canada 259
SE - Svezia 257
GB - Regno Unito 186
IE - Irlanda 183
UA - Ucraina 129
IN - India 121
FR - Francia 119
AT - Austria 90
PL - Polonia 89
FI - Finlandia 78
TR - Turchia 51
BD - Bangladesh 42
JP - Giappone 40
KR - Corea 40
ES - Italia 34
DK - Danimarca 31
BE - Belgio 30
IQ - Iraq 30
NL - Olanda 30
MX - Messico 26
AR - Argentina 25
ID - Indonesia 25
PK - Pakistan 19
ZA - Sudafrica 19
PH - Filippine 17
EG - Egitto 14
IR - Iran 14
EC - Ecuador 13
CO - Colombia 12
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
MA - Marocco 7
JM - Giamaica 6
JO - Giordania 6
LT - Lituania 6
TW - Taiwan 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
KE - Kenya 5
MY - Malesia 5
RO - Romania 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
IL - Israele 4
KZ - Kazakistan 4
PT - Portogallo 4
PY - Paraguay 4
CR - Costa Rica 3
LB - Libano 3
LY - Libia 3
NP - Nepal 3
PE - Perù 3
TN - Tunisia 3
AL - Albania 2
BO - Bolivia 2
EU - Europa 2
GR - Grecia 2
HN - Honduras 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
MT - Malta 1
PA - Panama 1
PS - Palestinian Territory 1
Totale 10.354
Città #
Ann Arbor 791
Singapore 608
Ashburn 417
Houston 305
Chandler 266
Hong Kong 257
Woodbridge 254
San Jose 243
Frankfurt am Main 180
Toronto 176
Dublin 174
Milan 169
Jacksonville 166
Dearborn 155
Wilmington 154
Fairfield 133
New York 131
Santa Clara 111
Ho Chi Minh City 109
Beijing 97
Los Angeles 86
Vienna 85
Dallas 72
Princeton 72
Hanoi 68
Kraków 65
Nanjing 62
Shanghai 58
Seattle 54
The Dalles 52
Chicago 47
Cambridge 45
Lachine 32
Pisa 32
São Paulo 32
Lauterbourg 31
Brussels 30
Buffalo 30
Munich 27
Seoul 27
Council Bluffs 26
Guangzhou 25
Lecco 24
Shenyang 24
Moscow 23
Da Nang 22
Orem 22
Tokyo 22
Dong Ket 21
Helsinki 21
London 21
Boardman 20
Fremont 20
Chennai 17
Ottawa 17
Pune 17
Tianjin 17
Changsha 16
Turku 16
Brooklyn 15
Jakarta 15
Manchester 15
Nanchang 15
Warsaw 15
Basingstoke 14
Phoenix 14
Amsterdam 13
Haiphong 13
Jinan 13
San Francisco 13
Zhengzhou 13
Andover 12
Hebei 12
Lawrence 12
Atlanta 11
Denver 11
Montreal 11
Stockholm 11
Baghdad 10
Edmonton 10
Falls Church 10
San Diego 10
Altamura 9
Lappeenranta 9
Rome 9
Ankara 8
Belo Horizonte 8
Campinas 8
Hefei 8
Johannesburg 8
Poplar 8
Rio de Janeiro 8
Hải Dương 7
Jiaxing 7
Lahore 7
Minya 7
New Delhi 7
Newark 7
Nuremberg 7
Tashkent 7
Totale 6.721
Nome #
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 486
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 467
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis 377
Micrornas in als: from molecular mechanisms to clinical relevance 366
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 357
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 353
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 350
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 347
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 326
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 323
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 318
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 314
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 309
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 308
Alterede miRNA in Amyotrophic Lateral Sclerosis: Searching for the Lowest Common Multiple 300
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 299
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 298
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 293
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 288
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 279
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 275
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 274
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 268
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 264
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 256
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 253
the MonzALS collaborative network 248
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 247
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 244
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 240
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 233
Study of transcriptional alterations in Amyotrophic Lateral Sclerosis 223
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 219
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 216
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 193
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 193
Totale 10.604
Categoria #
all - tutte 29.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 0 48 61
2021/2022413 29 65 45 27 31 30 14 39 25 18 35 55
2022/2023894 71 250 76 114 68 138 7 56 69 6 18 21
2023/2024614 29 26 16 23 77 188 100 27 20 17 11 80
2024/20251.421 75 172 131 47 123 57 51 65 172 239 122 167
2025/20263.743 445 139 263 434 529 223 563 156 358 358 275 0
Totale 10.604